Whitehawk Therapeutics, Inc. (WHWK) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.22 (+3.43%), Market cap $0.21B, 52-week low–high $1.60 ~ $5.10.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Financial statements, price targets, institutional (13F) holdings and related news for Whitehawk Therapeutics, Inc. are updated in real time on BlackAll Trade.
Whitehawk Therapeutics, Inc. trades at $4.22 (+3.43%). Real-time quotes and charts are available on BlackAll Trade.
Whitehawk Therapeutics, Inc. has a market cap of about $0.21B.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody dru